These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1383355)

  • 1. Effect of recombinant human granulocyte colony-stimulating factor (G-CSF) in the treatment of Pseudomonas aeruginosa bacteremia complicating hematologic malignancy--a preliminary study.
    Funada H; Machi T; Ohtake S; Yoshida T; Matsuda T
    Kansenshogaku Zasshi; 1992 Jan; 66(1):76-80. PubMed ID: 1383355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
    Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical approach to infection in patients with hematologic malignancy].
    Funada H
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):178-83. PubMed ID: 1371045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
    Toyama K; Yaguchi M; Mizoguchi H; Masuda M; Urabe A; Ikeda Y; Aoki I; Shinbo T; Togawa A; Hirashima K; Miura Y; Hirose S; Tsuruoka N; Omine M; Kamakura M; Saito T; Arimori S; Aoki N; Kuraishi Y; Hirai H; Asano S; Mori M; Shirai T; Muto Y; Takaku F
    Kansenshogaku Zasshi; 1996 Dec; 70(12):1242-53. PubMed ID: 9011117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of breakthrough bacteremia due to Pseudomonas aeruginosa with recombinant human granulocyte colony-stimulating factor in a patient with acute leukemia.
    Funada H; Mizuhashi K; Machi T; Ohtake S; Matsuda T
    Kansenshogaku Zasshi; 1991 May; 65(5):608-11. PubMed ID: 1715372
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis.
    Haberstroh J; Wiese K; Geist A; Dursunoglu GB; Gippner-Steppert C; Jochum M; von Specht BU
    Shock; 1998 Feb; 9(2):128-34. PubMed ID: 9488258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [III]. Prognostic factors].
    Funada H; Machi T; Matsuda T
    Kansenshogaku Zasshi; 1989 Aug; 63(8):880-5. PubMed ID: 2507688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1990 Aug; 64(8):994-1003. PubMed ID: 1698897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human granulocyte colony-stimulating factor infusion and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report.
    Chau WK; Lin CK; Chow MP; Wang SY; Liu JM; Ho CH; Chiu CF; Hsu HC; Tan TD; Chan WK
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):312-20. PubMed ID: 7530591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
    Gianni AM; Bregni M; Siena S; Magni M; Di Nicola M; Lombardi F; Tarella C; Pileri A; Bonadonna G
    J Clin Oncol; 1992 Dec; 10(12):1955-62. PubMed ID: 1280674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer.
    Eguchi K; Shinkai T; Sasaki Y; Tamura T; Ohe Y; Nakagawa K; Fukuda M; Yamada K; Kojima A; Oshita F
    Jpn J Cancer Res; 1990 Nov; 81(11):1168-74. PubMed ID: 1702415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [I]. Predisposing factors and clinical manifestations].
    Funada H; Machi T; Matsuda T
    Kansenshogaku Zasshi; 1989 Aug; 63(8):867-73. PubMed ID: 2507686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Granulocyte colony-stimulating factor combination therapy of acute myeloid leukemia complicated with severe infection].
    Miyabayashi M; Kitahara F; Ishii E; Koike K; Nakahata T; Komiyama A
    Rinsho Ketsueki; 1994 Jan; 35(1):65-8. PubMed ID: 7511180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.